Pricing Log in Create free account

Eli Lilly and Company (LLY) vs Novartis AG (NVS)

Eli Lilly and Company and Novartis AG are both Drug Manufacturers General companies. Eli Lilly and Company is the larger, with a market value of $1.18T against $275.3B — 4.3× the size. Novartis AG trades at the lower P/E: 22.6× against 42.2×. Eli Lilly and Company grew revenue faster over the last twelve months: 49.6% against 2.73%. Eli Lilly and Company has the higher net margin (33.5% vs 22.5%) and the higher return on invested capital (26.3% vs 13.1%). Both pay a dividend; Novartis AG yields more (3.15% vs 0.53%). Across the 23 metrics below, Novartis AG leads on 12 and Eli Lilly and Company on 11.

Valuation

Metric LLY NVS Drug Manufacturers General median
P/E 42.18 22.62 24.54
P/S 14.08 5.06 3.39
P/B 33.11 6.84 5.00
Price to free cash flow 55.01 18.91 16.55
EV/EBITDA 32.68 14.47 13.82
EV/Sales 14.66 5.76 4.03
Earnings yield 2.37% 4.42% 2.98%
Free cash flow yield 1.82% 5.29% 4.46%

Profitability

Metric LLY NVS Drug Manufacturers General median
Gross margin 83.40% 74.74% 72.77%
Operating margin 42.22% 30.17% 18.77%
Net margin 33.53% 22.50% 8.27%
Free cash flow margin 22.83% 26.77% 17.18%
Return on equity 102.29% 30.37% 5.87%
Return on assets 21.97% 11.27% 2.57%
Return on invested capital 26.33% 13.14% 6.11%

Growth

Metric LLY NVS Drug Manufacturers General median
Revenue growth (TTM) 49.58% 2.73% 6.66%
EPS growth (last fiscal year) 95.99% 21.81% 21.81%
Revenue growth, 5-year CAGR 21.58% 2.58% 4.75%
Net income growth, 5-year CAGR 27.22% 11.62% 0.00%

Health

Metric LLY NVS Drug Manufacturers General median
Debt to equity 1.62 1.12 0.63
Current ratio 1.35 0.86 1.32
Net debt to EBITDA 1.19 0.96 1.15

Dividend

Metric LLY NVS Drug Manufacturers General median
Dividend yield 0.53% 3.15% 2.33%
Payout ratio 0.22 0.72 0.59

Size

Metric LLY NVS Drug Manufacturers General median
Market cap 1.18t 275.28b 123.73b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack